TAM
PTCT icon

Tocqueville Asset Management’s PTC Therapeutics PTCT Stock Holding History

Tocqueville Asset Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-55,350
Closed -$545K – 822
2017
Q1 		$545K Sell
55,350
-730,625
-93% -$8.84M 0.01% 571
2016
Q4 		$8.57M Sell
785,975
-388,755
-33% -$4.08M 0.11% 212
2016
Q3 		$16.5M Sell
1,174,730
-225,913
-16% -$1.84M 0.2% 135
2016
Q2 		$9.83M Sell
1,400,643
-87,355
-6% -$641K 0.12% 197
2016
Q1 		$9.58M Buy
1,487,998
+516,205
+53% +$8.96M 0.13% 184
2015
Q4 		$31.5M Buy
971,793
+216,065
+29% +$6.36M 0.43% 63
2015
Q3 		$20.2M Buy
755,728
+178,350
+31% +$7.63M 0.27% 118
2015
Q2 		$27.8M Buy
577,378
+5,955
+1% +$347K 0.33% 93
2015
Q1 		$34.8M Sell
571,423
-31,885
-5% -$1.95M 0.41% 74
2014
Q4 		$31.2M Buy
603,308
+32,008
+6% +$1.41M 0.34% 98
2014
Q3 		$25.1M Buy
571,300
+299,487
+110% +$9.37M 0.28% 120
2014
Q2 		$7.11M Buy
271,813
+197,313
+265% +$4.22M 0.07% 261
2014
Q1 		$1.95M Buy
74,500
+9,450
+15% +$254K 0.03% 383
2013
Q4 		$1.1M Buy
65,050
+16,200
+33% +$285K 0.01% 434
2013
Q3 		$1.05M Buy
+48,850
New +$849K 0.01% 505

Other funds holding PTCT

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Tocqueville Asset Management's PTCT Position: Q2 2017 in Review

Tocqueville Asset Management sold out of PTC Therapeutics (PTCT) in Q2 2017, closing a stake of 55,350 shares — an estimated $545K sold.

Tocqueville Asset Management first reported a position in PTCT in Q3 2013 and held it in 15 quarters. The position peaked at $34.8M in Q1 2015. 114 funds tracked by Wall St. Rank hold PTCT as of Q2 2017.

  • Tocqueville Asset Management reported no remaining PTC Therapeutics position as of Q2 2017 after selling out during the quarter.
  • Tocqueville Asset Management sold 55,350 PTC Therapeutics shares in Q2 2017, an estimated $545K.
  • Tocqueville Asset Management first reported a position in PTC Therapeutics in Q3 2013 and held it in 15 quarters.
  • Tocqueville Asset Management's PTC Therapeutics position peaked at $34.8M in Q1 2015.
  • 114 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2017.

Based on Tocqueville Asset Management's 13F filing for Q2 2017, filed 4 Aug 2017.